TY - JOUR AU - Arulananda, Surein AU - Mitchell, Paul PY - 2018 TI - Elderly patients with stage III NSCLC survive longer when chemotherapy is added to radiotherapy—fortune favours the bold JF - Translational Lung Cancer Research; Vol 7, Supplement 4 (December 30, 2018): Translational Lung Cancer Research Y2 - 2018 KW - N2 - Around a third of non-small cell lung cancer (NSCLC) patients present with stage III disease. The majority are not suitable for surgery and until very recently, the standard-of-care for unresectable, good performance status patients with stage III disease has been platinum-doublet chemotherapy with high dose radiotherapy (RT), with no additional treatment. UR - https://tlcr.amegroups.org/article/view/23668